On March 11, 2020, the twenty-ninth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara …
On February 19, 2020, the twenty-eighth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara …
The MDMA Therapy Training team is currently focused on program development to support the growth of the training program for the years ahead. There are no dates scheduled for 2020 trainings yet. Dates …
In January 2020, we raised $74,191 in new donations and pledges from 845 supporters. Of that amount, $72,227 was for general support, $921 for Phase 3, $753 for Harm Reduction, and $250 for Ibogaine Research. …
Summary: Listen to Untangle, the podcast from Meditation Studio, to hear MAPS Founder Rick Doblin, Ph.D., share his insights on the role psychedelics may play to overcome fear, heal trauma, promote connection, …
Summary: Learn about psychedelic harm reduction and techniques to support someone going through a challenging experience by listening to a recent episode of Life is a Festival Podcast with the Zendo Project’s …
May 1-2, 2020 From the event website: Non-ordinary states of consciousness have played an important role in psychotherapy since its inception. For example, dreams, hypnotic trance, free association, and …
April 25, 2020 From the event website: Topics include: physical, mental, and emotional effects of psychedelics; factors that contribute to a difficult experience; Zendo Project’s four principles of psychedelic …
The Women in Cannabis Study, founded by Jennifer Whetzel and supported by partner Wholf Research and Consulting, is the first-ever global, comprehensive quantitative study on women in the cannabis industry …
Summary: In a short video, Unpacked interviews Keren Tzarfaty, Ph.D., M.F.T., Director of Israeli Projects and Collaborations at MAPS. Tzarfaty explains that MDMA-assisted psychotherapy sessions may allow …
On January 30, 2020, the U.S. Food and Drug Administration (FDA) issued a second Continued Partial Clinical Hold Letter that only briefly restated the issues raised in its prior two hold letters, noting …
